Cell Therapy Technologies Market worth USD 5.6 billion by 2025 - Leading Companies are Lonza Group, Sartorius AG, Avantor, Inc, Bio-Techne Corporation, Corning Incorporated, STEMCELL Technologies, Hemasoft, MAK-SYSTEM, OrganaBio, LLC, IxCells Biotechnolog
The Cell Therapy Technologies Market is projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 14.4% from 2020 to 2025.
Download PDF Brochure:
The growth of this market is driven by the rising government investments in cell-based research, increasing incidence of chronic and infectious diseases, a large number of oncology-related cell therapy clinical trials, and increasing GMP certifications for cell therapy production facilities.
"Consumables is expected to hold the largest share of the cell therapy technologies market, by product in 2020."
On the basis of product, the market is segmented into consumables, equipment, and systems & software. The consumables segment accounted for the largest share of the market in 2019. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.
"T-cells is expected to hold the largest share of the cell therapy technologies market, in 2020."
On the basis of cell type, the market is segmented into T-cells, stem cells, and other cells. In 2019, T-cells accounted for the largest share of the market. Favorable government initiatives and the increasing demand for T-cell therapies are the key factors driving the growth of this segment.
Browse in-depth TOC on "Cell Therapy Technologies Market"
106 – Tables
41 – Figures
173 – Pages
Get 10% Customization on this Research Report:
"Cell processing is expected to hold the largest share of the market in 2020."
On the basis of process, the market is segmented into cell processing, cell preservation, distribution and handling, and process monitoring and quality control. The cell processing segment dominated the market in 2019. This segment is expected to grow at the highest CAGR during the forecast period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.
"Biopharmaceutical & biotechnology companies and CROs segment commanded the largest share of the market in 2020."
By end user, the cell therapy technologies market is segmented into biopharmaceutical & biotechnology companies and CROs and research institutes, and cell banks. Biopharmaceutical & biotechnology companies and CROs dominate the market and are expected to grow at the highest CAGR. The large share of this regional segment can primarily be attributed to the high burden of chronic diseases and increasing R&D activities in the pharmaceutical and biotechnology industries.
"North America commanded the largest share of the cell therapy technologies market in 2020."
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.
Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=213334978#utm_source=Openpr&utm_medium=paidpr
The major players operating in this cell therapy technologies market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany). MaxCyte (US), Danaher Corporation (US), and Becton, Dickinson and Company (US), Lonza Group (Switzerland), Sartorius AG (Germany), Terumo BCT (US), Fresenius Medical Care AG & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte (US), Werum IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), CellGenix GmbH (Germany), L7 Informatics, Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), Hemasoft (US), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology (China), and Wilson Wolf Corporation (US).
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's™ flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell Therapy Technologies Market worth USD 5.6 billion by 2025 - Leading Companies are Lonza Group, Sartorius AG, Avantor, Inc, Bio-Techne Corporation, Corning Incorporated, STEMCELL Technologies, Hemasoft, MAK-SYSTEM, OrganaBio, LLC, IxCells Biotechnolog here
News-ID: 2193295 • Views: 1089
More Releases from MarketsandMarkets
Silicone Market worth $23.3 billion by 2025 | Key Players include Dow, Wacker Ch …
According to recent market research "Silicone Market by Type (Elastomers, Fluids, Resins, Gels), End-use Industry (Industrial Process, Building & Construction, Personal Care & Consumer Products, Transportation, Electronics, Medical & Healthcare, Energy), Region - Global Forecasts to 2025", size is expected to grow from USD 14.0 billion in 2020 to USD 23.3 billion by 2025, at a CAGR of 10.7% during the forecast period. The major factors driving the silicone industry
Portable Projector Market worth $1.9 billion by 2025
The report "Portable Projector Market with COVID-19 Impact Analysis, Technology (DLP,LCD, LCOS), Dimension (2D,3D), Lumen(Below 500, 500 to 3,000, Above 3,000), Resolution(VGA,XGA, HD & FHD), Projection, Application, and Region - Global Forecast to 2025", is projected to grow from USD 1.5 billion in 2020 to USD 1.9 billion by 2025; it is expected to grow at a CAGR of 4.3% from 2020 to 2025. The key factors fueling the growth
Marine Battery Market worth $812 million by 2025
The report "Marine Battery Market by Battery Type (Lithium, Fuel Cell, Lead-acid), Propulsion Type (Fully Electric, Hybrid, Conventional), Application, Sales Channel, Ship Range, Nominal Capacity, Battery Design, Battery Function, and Region - Global Forecast to 2025", is estimated to be USD 250 million in 2020 and is projected to reach USD 812 million by 2025, at a CAGR 48.1% from 2020 to 2025. Implementation of sulfur 2020 rule and rise
Crystal Oscillator Market worth $3.1 billion by 2025
The report "Crystal Oscillator Market with COVID-19 Impact Analysis by General Circuity (SPXO, TCXO, VCXO), Crystal Cut (AT Cut, BT Cut, SC Cut), Mounting Scheme (Surface Mount, Through-Hole) Application (Consumer Electronics), Geography - Global Forecast to 2025",, size is projected to reach USD 3.1 billion by 2025 from an estimated USD 2.8 billion in 2020, at a CAGR of 2.1% from 2020 to 2025. Rising development of 5G networks is
More Releases for Cell
Single Cell Analysis Market
Single Cell Analysis Market Size Worth $ 4,752.19 Million By 2026 | CAGR: 18.4% The global Single Cell Analysis market size is expected to reach USD 4,752.19 million by 2026 according to a new study by WhipSmart MI Research. The report “Single Cell Analysis Market By Product (Consumables and Instruments), Cell Type (Human, Microbial and Animal), Technique (Flow Cytometers, Next-Generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry and Other Techniques), Application
Fuel Cell Vehicle Market
The report aims to provide an overview of the global Fuel Cell Vehicle Market with detailed market segmentation by technology, vehicle type, and geography. The global fuel cell vehicle market is expected to witness high growth during the forecast period. The fuel cell vehicle market report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market. Get Sample Copy of
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents Introduction to Cell Therapy Necessity for Cell Therapy Treatment 2.1 Emergence of Stem Cell Research 2.2 Benefits of Using the Stem Cell for Research and Treatment Application of Stem Cells in Cell Therapy 3.1 Stem Cells Ability to Differentiate 3.1.1 Totipotent Stem Cells 3.1.2 Pluripotent Stem Cells 3.1.3 Multipotent
Cell Science 2017
It takes us immense pleasure to announce the conference that “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine” which is going to be held during November 29-30, 2017 at Atlanta, USA. Cell Science 2017 conference will focus on the latest and exciting innovations in all areas of Cell Biologists and Stem Cell Researchers which offer a unique opportunity for investigators across the globe to meet, network, and perceive